Patents by Inventor S. Cyrus Khojasteh

S. Cyrus Khojasteh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hexahydropyrazolo[4,3,-c]pyridine metabolites
    Patent number: 6531449
    Abstract: The invention provides metabolites of the compound 2-amino-N-[2-(3a(R)-benzyl-2-methyl-3-oxo-2,3,3a,4,6,7-hexahydro-pyrazolo-[4,3-c]pyridin-5-yl)-1-(R)-benzyl-oxymethyl-2-oxo-ethyl]-isobutyramide, the racemic-diastereomeric mixtures and optical isomers thereof, the prodrugs thereof, and the pharmaceutically acceptable salts of the metabolites, racemic-diastereomeric mixtures, optical isomers, and prodrugs; to pharmaceutical compositions thereof; and to methods of using the metabolites and the compositions in the treatment of diseases associated with reduced levels of growth hormone.
    Type: Grant
    Filed: March 8, 2001
    Date of Patent: March 11, 2003
    Assignee: Pfizer Inc.
    Inventors: S. Cyrus Khojasteh, John P. O'Donnell
  • Hexahydropyrazolo[4,3,-c]pyridine metabolites
    Publication number: 20020002138
    Abstract: The invention provides metabolites of the compound 2-amino-N[2-(3a(R)-benzyl-2-methyl-3-oxo-2,3,3a,4,6,7-hexahydro-pyrazolo-[4,3-c]pyridin-5-yl)-1-(R)-benzyl-oxymethyl-2-oxo-ethyl]-isobutyramide, the racemic-diastereomeric mixtures and optical isomers thereof, the prodrugs thereof, and the pharmaceutically acceptable salts of the metabolites, racemic-diastereomeric mixtures, optical isomers, and prodrugs; to pharmaceutical compositions thereof; and to methods of using the metabolites and the compositions in the treatment of diseases associated with reduced levels of growth hormone.
    Type: Application
    Filed: March 8, 2001
    Publication date: January 3, 2002
    Inventors: S. Cyrus Khojasteh, John P. O'Donnell